| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |